Yukon, OK – Tekton Research, a leader in clinical research, is thrilled to announce an impactful collaboration with esteemed Neurologist, Dr. David McCoy.
Tekton Research is dedicated to conducting a wide range of clinical trials for pharmaceutical and device companies, with a steadfast focus on knowledge, expertise, and unwavering integrity.
As the field of clinical research advances to enhance patient care across diverse platforms in the United States, Tekton Research remains at the forefront. This mission has propelled Tekton to expand its reach into the Yukon area through its latest partnership with Neurologist, Dr. David McCoy.
A true Oklahoman native, Dr. McCoy’s roots lie in the West Oklahoma City/Yukon region. He pursued his undergraduate studies at the University of Central Oklahoma on an academic scholarship, graduating with the highest honor of summa cum laude. He successfully concluded an internship in General Internal Medicine at the University of Oklahoma Health Sciences Center and pursued his training at the same institution, eventually specializing through Oklahoma’s prestigious ACGME-accredited Neurology Residency Program.
Dr. McCoy holds an unrestricted medical license from the Oklahoma State Board of Medical Licensure and Supervision. He is doubly certified by the American Board of Psychiatry and Neurology as well as the National Board of Physicians and Surgeons. Additionally, he is an esteemed member of the American Academy of Neurology, proudly standing as the sole board-certified neurologist in all Canadian counties.
Together, Tekton and Dr. McCoy are eager to deliver an elevated standard of patient-centric care, leading to breakthroughs in healthcare that benefit one and all.
